Protecting Clients Coast to Coast

For 30 years, Faruqi & Faruqi has been dedicated to protecting the rights of shareholders, employees, and consumers through integrity, respect, and results. 

Who We Are

Over 30 Years Of Working Experience In Legal Solutions

Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action and Wage & Hour litigation.

Take Action

View our active case list and determine whether you want to participate in an action with us now
View All
Inform us of any fraud or unfair business practice using the link below
Report a Fraud
A class action suit can provide merger scrutiny to ensure you are protected
Merger Information
What we do

Client Services

Faruqi & Faruqi strives to provide exceptional client services. These services include:
Portfolio Monitoring
We review the investment portfolios of institutional clients and prepare detailed reports.
Learn More
Corporate Governance and Regulatory Compliance
We monitor changes in the law to protect shareholders from corporate non-compliance.
Learn More
Case Evaluation
We perform complex damage analyses to evaluate the merit of clients’ cases.
Learn More
Practice Areas

Our Legal Work

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia, and Pennsylvania.

Are You an Affected Shareholder?

Faruqi & Faruqi, LLP is actively investigating the following cases:
30 Oct 2025
Avantor, Inc.
Did You Lose Money in Avantor, Inc. (NYSE: AVTR) Stock? Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Avantor’s competitive positioning was weaker than Defendants had publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, Defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. Lead Plaintiff Deadline: December 29, 2025 📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) 💻 Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
58 Days
Take Action
30 Oct 2025
Wildermuth Fund
If you suffered significant losses in The Wildermuth Fund and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Wildermuth Fund (“Wildermuth Fund” or the “Company”) (NASDAQ: WESFX,WEFCX,WEIFX). On June 29, 2023, the Fund announced that, based upon the recommendation of the Adviser, the Fund’s Board of Trustees had approved a plan of liquidation for the Fund (the “Liquidation Plan”). The Adviser Defendants reassured investors that there were no issues with the underlying investments held by the Fund and the Fund continued trading at or around a NAV of $10 per share. The reason for the liquidation stemmed from the loss of certain tax advantages. On November 1, 2023, Daniel and Carol Wildermuth resigned from the Board and from their roles as officers of the Fund. Daniel Wildermuth further resigned as Chairman of the Board and the agreement with the Adviser was terminated. The Board replaced Wildermuth Advisory with BW Asset Management Ltd. (“BWAM”), a subsidiary of Kroll, as the Fund’s investment adviser. Compared with reported values in March 2022, by October 2024, the value of the Fund’s investments had dropped by 63.6% and the NAV had declined by 73.7%. Compared to the values reported in March of 2023, by October 2024, the value of the Fund’s investments had dropped by 47.4% and the NAV had declined by 57.7%, in comparison to the March 2023 valuations. Finally, by 2024, Kroll revised its NAV to less than $2.00 per share, an 80% reduction in NAV per share.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
58 Days
Take Action
30 Oct 2025
Stride, Inc.
If you suffered significant losses in Stride stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN). STOCK DROP: On September 14, 2025, Simply Wall St. published a report stating that the Gallup-McKinley County Schools Board of Education had filed a complaint against Stride, alleging fraud, deceptive trade practices, systemic violations of law, and intentional and tortious misconduct, including inflating enrollment numbers by retaining “ghost students” on rolls to secure state funding per student and ignoring compliance requirements, including background checks and licensure laws for its employees. On this news, Stride’s stock price fell $18.60, or 11.7%, to close at $139.76 per share on September 15, 2025, thereby injuring investors. Then, on October 28, 2025, Stride released its first quarter fiscal 2026 financial results, revealing the Company had purposely “limit[ed] enrollment growth while we improve our execution.” The Company also revealed it had experienced “system implantation issues” resulting in “higher withdrawal rates and lower conversion rate.” The Company stated that “these factors resulted in approximately 10,000 to 15,000 fewer enrollments” and “these challenges will likely restrict [its] in-year enrollment growth.” On this news, Stride’s stock price fell as much as 51% during intraday trading on October 29, 2025, thereby injuring investors further.
James M. Wilson, Jr.
Robert W. Killorin
Take Action
28 Oct 2025
Nidec Corporation
If you suffered significant losses in Nidec stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nidec Corporation (“Nidec” or the “Company”) (OTC: NJDCY). STOCK DROP: On September 3, 2025, Nidec disclosed it had established a third-party committee to investigate suspicions of improper accounting. The Company further revealed its “investigations found multiple documents suggesting that . . . the Company and its group companies could have engaged in improper accounting with the involvement or knowledge of its or their management[.]” On this news, Nidec’s stock price fell $0.81, or 16.5%, to close at $4.11 per share on September 4, 2025, thereby injuring investors. Then, on September 26, 2025, Nidec disclosed further investigative findings of additional suspected inappropriate accounting practices, including “cases where the reported value for customs purposes was declared to be lower than the appropriate amount without legitimate reason.” The Company also revealed that it “received an audit report containing a disclaimer of opinion” from its auditor due to the “ongoing investigations by the third-party committee, other internal investigations, and other action[s].” On this news, Nidec’s stock price fell $0.29, or 6.6%, to close at $4.09 per share on September 26, 2025. Then, on October 23, 2025, Nidec published a press release announcing that it was withdrawing its year end forecast, and had decided not to pay a surplus dividend as “investigations by the Third Party Committee regarding suspected inappropriate accounting practices involving the Company and its group, as well as other internal investigations, are ongoing.” On this news, Nidec’s stock price fell $1.17, or 25.4%, to close at $3.43 on October 23, 2025. Finally, on October 27, 2025, the Tokyo Stock Exchange (“TSE”) designated Nidec under a Special Security alert in part because “TSE deems that the improvement of the internal management system of said listed company is highly necessary.” The alert noted that “[s]ince the initial issue was discovered, the scope of the investigation has continued to expand” and that “deficiencies have already been identified in the Company’s company-wide internal control systems (particularly in areas related to information and communication), as well as in the internal controls related to its accounting and financial closing processes.” On this news, Nidec’s stock price fell $0.80, or 20.3%, to close at $3.15 per share on October 27, 2025, thereby injuring investors further.  
James M. Wilson, Jr.
Robert W. Killorin
Take Action
Testimonials

Court Praises

Updates from Us

Latest News

See All
12 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Luminar Technologies Securities Litigation and Advances the Case to Discovery
Read More
4 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Sun-Maid Litigation
Read More
7 Apr 2025
Faruqi & Faruqi, LLP has been ranked in Chambers and Partner’s New York Chambers Spotlight 2025 Guide and recognized as a leader in the employment litigation industry
Read More

From the Blog

See All
29 Oct 2025
New York City Council Passes Pay Data Reporting Law For Private Employers
Read More
24 Oct 2025
Alleged Pig Butchering Scam Kingpin Charged By DOJ; Agency Seizes A Record $15 Billion In Bitcoin
Read More
23 Oct 2025
Starbucks Case Shows Why Lactation Rights Matter at Work
Read More

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771